Primary study · included by 1 review

Salivary Gland Function 5 Years After Radioactive Iodine Ablation in Patients with Differentiated Thyroid Cancer: Direct Comparison of Pre- and Postablation Scintigraphies and Their Relation to Xerostomia Symptoms

Jeong 2013 · Jeong Shin Young, Kim Hae Won, Lee Sang-Woo, et al. · Thyroid · 2013

Included by

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.
Non-Cochrane · prognostic · 2026 · cited as Jeong 2013 · Reference list; Fig. 1-3
Outcome this study informsPooled effectEvidenceCertainty
Xerostomia (pooled prevalence)
Radioiodine (I131) therapy · within 2 months after RIT
Prevalence 0.60 [0.28, 0.85]3 studies · 1502 participantsGRADE not reported

1 including review in total.